LG Debuts 5MP High-Definition Mammography Monitor
Intended for mammography and digital breast tomosynthesis (DBT) interpretation, the device reportedly emphasizes high-definition image quality and ease of use for radiologists.
Offering enhanced visualization of mammography and other breast imaging, LG has launched the 21HQ613D-B diagnostic monitor, which allow for high-definition views on a 21.3-inch, 5-megapixel (MP) platform.
Emphasizing the image quality of the 21HQ613D-B device, LG noted the monitor, which received FDA clearance in February 2024, gives radiologists 2,048 x 2,560 resolution, 1,100 cd/m2 luminance and an 1800:1 contrast ratio.
Cleared by the FDA in February 2024, the newly launched 21HQ613D-B diagnostic monitor offers radiologists 2,048 x 2,560 resolution, 1,100 cd/m2 luminance and an 1800:1 contrast ratio, according to LG, the manufacturer of the device. (Image courtesy of LG.)
While the 21HQ613D-B diagnostic monitor is intended for the assessment of digital mammography and digital breast tomosynthesis (DBT), LG noted that radiologists can also utilize the monitor for review of breast magnetic resonance imaging (MRI), computed tomography (CT) or ultrasound images.
The 21HQ613D-B diagnostic monitor also has a Focus View Mode, which allows radiologists to highlight a key part of an image, and a Multi-Resolution Mode, which facilitates resolution adjustments to optimize viewing of different images, according to LG.
"LG's new 5MP diagnostic monitor is tailored for reviewing mammograms and breast tomosynthesis, providing a high-quality medical imaging display with both simple management and practical features for users,” said Stephen K. Hu, the head of medical displays for LG Business Solutions USA. “We’re dedicated to providing cutting-edge solutions for the medical sector with our display technologies, and the addition of the latest 5MP monitor underscores this commitment to innovation.”
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
